|
| Exchange Received Time 10/06/2019 19:02:20 Exchange Disseminated Time 10/06/2019 19:02:27 Time Taken 00:00:07 | | Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/06/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors will be held on Thursday, June 13, 2019, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of the Company. |
|
|